Companies should expect higher FDA scrutiny;
Chemwerth positioned well to help customers.

Peter Werth continues to make news as a thought leader in the generic API world.

CHEMANAGER features ChemWerth on page 13 and discusses Peter’s expectations that the FDA will ratchet up its approach to ensure that manufacturers around the globe adhere to strict cGMP compliance. Peter also talks about the importance of partnering with full service API suppliers who have the expertise to help companies more tightly manage their supply chains to bring affordable generic drugs to market quickly and safely. Click the link below to read the article.

http://corporate.gitverlag.com/media/blaetterkatalog/cmi/2009-10/index.html?lang=en_GB

<< Return to ChemWerth News